NEW YORK, December 14 - Rosetta Inpharmatics inaugurated Thursday a new gene
expression profiling facility in Bothell, Wash.

At the facility, researchers will use image analysis technology and
molecular biology processes to generate gene expression data for drug and
drug target discovery, the company said.

" Our new facility in Bothell will help us further our efforts in gene
expression research, and will advance our goal to develop solutions that
will accelerate and enhance the drug discovery process," said Rosetta CEO

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Congress approved a bill Friday that would increase the US National Institutes of Health's funding by $2 billion for fiscal year 2019.

Sarah Lawrence College's Laura Hercher warns in a New York Times op-ed that more people are going to need help figuring out what their consumer genetic testing results mean.

UK's Labour Party calls for a ban on non-invasive prenatal testing for determining sex, BBC News reports.

In PLOS this week: intra-tumor heterogeneity patterns, genomic analysis of Thoroughbred horse origins, and more.